Immunochemistry reagents

Ended Indefinite Delivery Contract Awarded Last action

Contract number
W81K0021D0007
Awardee
Awarding agency
Task orders
3 $2,599,974 obligated

Award facts

Opportunity
Combined order value
$4,491,916 Current and potential, with all options
Last date to order 100% complete
IDV ceiling 69% used
$3,783,883.88
Award type
Single award
Who can order
Only the awarding agency
Contracting staff
Funding agency
Defense Health Agency Department of Defense
Set-aside
No set-aside
Competition
Not Competed · 1 offer Only One Source
Pricing
Firm Fixed Price

Award details come from SAM.gov/FPDS.

About this IDV

Abbott Laboratories Inc., through its Abbott Diagnostics Division, has been awarded an indefinite delivery contract by the Defense Health Agency to provide immunochemistry reagents. The contract has a potential value of $3.78 million and a period of performance through September 2023. Task orders issued to date include a $1.4 million order for the Defense Health Agency and orders valued at $1.89 million and $1.2 million for the Department of the Army Medical Command. Performance will take place at Abbott's facility in North Chicago, Illinois.

The original solicitation from the Regional Health Contracting Office - Central indicated intent to sole source award a bridge contract to Abbott Laboratories for provision of a fully automated laboratory, including leased equipment, analyzers, required reagents, and maintenance services to Carl R. Darnall Army Medical Center at Fort Hood, Texas. The scope of work under the indefinite delivery contract and subsequent task orders encompasses supplying immunochemistry reagents in support of clinical laboratory operations and medical research activities for the Defense Health Agency and Army Medical Command facilities. Abbott Laboratories will utilize its existing contracts and supply chain to streamline delivery of these essential products.

Task orders

Task order Ordering agency Obligated Awarded
Immunochemistry reagents W81K0022F0033 Medical Command (Army) $1,401,942
Immunochemistry reagents W81K0022F0013 Medical Command (Army) $1,198,032
Immunochemistry reagents W81K0021F0131 Medical Command (Army) $0

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00002 $0
Exercise an Option P00001 $0
Original award $0

Quick answers

Who was awarded contract W81K0021D0007?

W81K0021D0007 was awarded to Abbott Laboratories Inc. by Medical Command (Department of the Army) on October 1, 2021.

How much is contract W81K0021D0007 worth?

Orders under W81K0021D0007 have obligated $2,599,974. Their combined current value, with exercised options, is $4,491,916. W81K0021D0007's own ceiling is $3,783,884.

How many orders have been placed under contract W81K0021D0007?

3 orders have been placed under W81K0021D0007, the latest on October 1, 2022.

Which agency awarded contract W81K0021D0007?

Medical Command (Department of the Army) awarded W81K0021D0007, with funding from Defense Health Agency (Department of Defense).

Who can order from contract W81K0021D0007?

W81K0021D0007 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.

Was contract W81K0021D0007 competed?

The extent of competition for W81K0021D0007 was not competed. The government received 1 offer.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV